ASX Share rice
Tue 04 Aug 2020 - 02:41:pm (Sydney)

DXB Share Price

DIMERIX LIMITEDDXBPharmaceuticals, Biotechnology & Life Sciences

DXB Company Information


Dimerix Limited





GIC Industry:


GIC Sub Industry:



425 Smith Street Fitzroy VIC Australia 3065


61 8 9388 8290

Exec. Chairman:

Dr. James Howard Williams M.B.A., BSc (Hons), Ph.D., MBA, GAICD

CEO, MD & Director:

Dr. Nina Webster Ph.D., M.IP.Law, MBA

CFO & Company Sec.:

Mr. Hamish George B.Com., C.A.

Chief Scientific Advisor:

Mr. Kevin Donald George Pfleger BA (Hons), MA, Ph.D.

Bus. Devel. Officer:

Ms. Elizabeth McCall B.Com., L.L.B., LLB., B.Juris, B.Com(Hons), GAICD

Company Overview:

Dimerix Limited, a clinical stage biotechnology company, develops and commercializes new therapies in the area of unmet medical needs. Its lead product candidate is DMX-200, which is in Phase II clinical trial for the treatment of diabetic kidney diseases and focal segmental glomerulosclerosis. The company is headquartered in Fitzroy, Australia.

DXB Share Price Information

Shares Issued:


Market Capitalisation:


Revenue (TTM):


Revenue Per Share (TTM):


Earnings per Share:


Operating Margin (TTM):


Return On Assets (TTM):


Return On Equity (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


Diluted Earnings Per Share (TTM):


DXB CashFlow Statement

CashFlow Date:




Change To Liabilities:


Total Cashflow From Investing Activities:


Net Income:


Total Cash From Operating Activities:




Change To Account Receivables:


Capital Expenditures:


DXB Income Statement

Income Date:


Income Before Tax:


Net Income:


Gross Profit:


Operating Income:


Total Revenue:


Total Operating Expenses:


DXB Balance Sheet

Balance Sheet Date:


Total Liabilities:


Total Stockholder Equity:


Other Current Liabilities:


Total Assets:


Common Stock:


Retained Earnings:




Total Current Liabilities:


Property - Plant & Equipment:


Net Tangible Assets:


Total Current Assets:


Net Receivables:


Short-Term Investments:


Accounts Payable:


Non Currrent Assets (Other):


Short-Term Investments:


Non Current Liabilities Total:


DXB Share Price History

DXB News

29 Jul, 2020
Dimerix reported excellent results from the clinical trial of drug DMX-200 aimed at rare kidney disease focal segmental glomerulosclerosis (FSGS)
04 May, 2020
We can readily understand why investors are attracted to unprofitable companies. For example, Dimerix (ASX:DXB...
05 Feb, 2020
If you want to compound wealth in the stock market, you can do so by buying an index fund. But if you pick the right...
07 Nov, 2019
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
23 Sep, 2019
If you want to know who really controls Dimerix Limited (ASX:DXB), then you'll have to look at the makeup of its share...
08 Aug, 2019
If you're interested in Dimerix Limited (ASX:DXB), then you might want to consider its beta (a measure of share price...